Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma †
Titel:
Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma †
Auteur:
Al-Batran, S.-E. Van Cutsem, E. Oh, S.C. Bodoky, G. Shimada, Y. Hironaka, S. Sugimoto, N. Lipatov, O.N. Kim, T.-Y. Cunningham, D. Rougier, P. Muro, K. Liepa, A.M. Chandrawansa, K. Emig, M. Ohtsu, A. Wilke, H.